This week our Life Sciences team published the first edition of its Cross-border Guide to Clinical Trials and Privacy. The Guide will...
Cortex - Life Sciences Insights
/Passle/596df0e43d947619ec025f26/MediaLibrary/Document/2023-02-06-15-22-11-857-DLAPiper-LifeSciences-PolandJanuaryUpdate_thumbnail_1.png)
Download a copy of our January monthly briefing, which covers key updates and insights in the following areas: Pharmacies; Clinical...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2023-02-06-09-38-23-645-63e0ca8ff636e91420348d60.jpg)
On 31 January 2023, the new Clinical Trials Information System (CTIS) established by Regulation (EU) 536/2014 on clinical trials (CTR)...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2023-01-31-19-32-18-705-63d96cc2f636e91244578d2b.jpg)
Early this year, the Portuguese Minister of Health stated the public expense with medicines in 2022 showed an increase of more than EUR...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2023-01-30-14-21-14-078-63d7d25af636ea1514066fe8.jpg)
The Swedish government has on 24 January 2023 proposed a bill with actions aimed at improving the availability of medicines. The bill...
/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/5ed622ef8cb62a041c7fddf8/2023-01-19-19-03-03-073-63c993e7f636e90d34f7fa77.PNG)
We would like to invite you to read our report summarising the second edition of the DLA Piper survey "Pharmaceutical and medical sector...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2023-01-19-15-08-50-911-63c95d02f636e90fa01d8325.jpg)
During the World Economic Forum 2023 in Davos, specialists discussing the topic of health unanimously indicated that “the past three...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2023-01-18-09-41-45-799-63c7bed9f636e909545803c1.jpg)
On December 29, 2022, President Biden signed the Consolidated Appropriations Act, 2023 into law, which contains the Food and Drug Omnibus...
/Passle/596df0e43d947619ec025f26/MediaLibrary/Document/2023-01-12-12-45-06-630-DLAPiperLifeSciences-PolandBriefing-December2022_thumbnail_1.png)
Download a copy of our December monthly briefing, which covers key updates and insights in the following areas: Clinical trials;...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2023-01-11-16-25-41-574-63bee305f636ea1e240f67fe.jpg)
The New Zealand government has introduced the Therapeutic Products Bill which is intended to replace the existing medicines, medical...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2023-01-10-12-01-31-639-63bd539bf636e9183071efa0.jpg)
The FDA has denied two citizen petitions filed on behalf of the Informed Consent Action Network (ICAN) requesting the agency revoke its...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2023-01-06-10-23-16-910-63b7f694f636ea1ad8e2046b.jpg)
The American Enterprise Institute (AEI), a public policy think tank, published a piece this week by Kirsten Axelsen on the potential cost...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2023-01-03-10-26-59-525-63b402f3f636e917189a4c4d.jpg)
APIFARMA – Portuguese Pharmaceutical Industry Association (Apifarma) recently approved a revision to the Code of Ethics for Promotion...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2022-12-19-13-42-59-346-63a06a63f636e919907aa3e4.jpg)
The FDA has denied two citizen petitions filed on behalf of the Informed Consent Action Network (ICAN) requesting the agency revoke its...
/Passle/596df0e43d947619ec025f26/MediaLibrary/Document/2022-12-08-09-42-16-699-DLAPiper-PolandLifeSciences-November2022update_thumbnail_1.png)
We first wrote about the planned amendments to the Pharmaceutical Law and certain other acts (the so-called Verticalisation Act) in...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2022-12-01-13-46-46-752-6388b046f636e913f4268c69.jpg)
The FDA recently published “Sameness Evaluations in an ANDA – Active Ingredients,” a new draft guidance detailing recommendations for...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2022-11-21-10-55-02-510-637b5906f636e90c649dd31e.jpg)
As someone who believes strongly in empowering women in the workplace and building a diverse and inclusive culture, I really enjoyed...